Allarity Therapeutics $3M Debt Financing with Streeterville Capital, LLC
Allarity Therapeutics entered into an exchange agreement with Streeterville Capital to partition $3.0 million from an existing $10.93 million promissory note. The partitioned debt was exchanged for 3,000 shares of newly designated Series B Preferred Stock, effectively reducing the company's outstanding debt balance by $3.0 million. The Series B Preferred Stock carries a 9% annual dividend and ranks senior to common stock in liquidation.
- Value
- $3M
- Counterparty
- Streeterville Capital, LLC